This article comprehensively reviews the application of machine learning (ML) models for early-stage colorectal cancer (CRC) detection, a critical focus for improving patient survival outcomes.
This article addresses the critical challenge of developing robust cancer prediction models when genomic data is scarce, a common scenario in clinical and research settings.
This article provides a comprehensive exploration of whole-genome sequencing (WGS) of plasma cell-free DNA (cfDNA) for cancer detection, tailored for researchers and drug development professionals.
This article provides a comprehensive overview of feature selection strategies specifically designed for high-dimensional genomic data, addressing the critical p >> n problem prevalent in modern bioinformatics.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on leveraging public datasets for cancer DNA sequence analysis.
This article provides a comprehensive analysis of the role of gene expression analysis in early cancer detection for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide to performance metrics for cancer classification models, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive examination of test-retest reliability in radiomic features, a critical foundation for developing robust imaging biomarkers.
This article provides a comprehensive comparison for researchers and drug development professionals between traditional cancer diagnostics and emerging artificial intelligence (AI)-based approaches.
The translation of artificial intelligence (AI) models from promising research tools to reliable clinical assets hinges on robust validation across diverse, multi-center datasets.